“Increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments.”

—World Health Organization 2003 – Non-communicable Diseases and Mental Health Adherence to Long-term Therapies Project

Key Management

David Rosa is the Founder and President of CTA. Mr. Rosa maintains his responsibilities for corporate governance and vision, managing the current consulting practice, and working to grow alliances with other companies that will further enhance the value of the Simpill partnership and CTA in general.

Mr. Rosa has worked within the biopharmaceutical industry for nearly 20 years. He has a M.S. in biostatistics from the University of Massachusetts at Amherst School of Public Health and initially worked as a project manager and statistician for Consulting Statisticians, Inc., who was acquired by PAREXEL. While part of PAREXEL, Mr. Rosa moved from his statistical role into the business development arena where he was responsible for managing large pharmaceutical accounts and some emerging biotechnology companies. After leaving PAREXEL, Mr. Rosa held various positions at Vertex Pharmaceuticals, InSite Clinical Trials, and MTRA (now aaiPharma).

In late 1997, Mr. Rosa was asked by Dr. Paul Bleicher (a former PAREXEL colleague) to join his start-up company, Phase Forward, Inc. Mr. Rosa assumed the role of Sales and Marketing Director and was responsible for launching their InForm electronic data capture product, overseeing the marketing responsibilities of the product and generating the initial sales of the product to the first customers. He then became a Sales Director for the major accounts using the InForm product.

In June of 2000, Mr. Rosa joined Invivodata, inc., a leader in the field of electronic patient diaries. As Vice President of Sales, Mr. Rosa drove the initial sales of the organization and helped to promote the capture of patient self-report data using handheld (Palm) technology. He also opened the international market for Invivodata by winning their initial global projects. Recently, as a Sales Director, Mr. Rosa has been responsible for managing the Northeast US and several key strategic accounts.

As the founder and President of Clinical Technology Advisors, Mr. Rosa's commitment is to bring technology companies across the chasm that separates them from the clinical trials industry.
 

Paul Molinari is the company’s Vice President of Marketing and Business Operations. He is responsible for the marketing and promotion of CTA. He is also responsible for developing the direct-to-consumer strategy for the Simpill system, including the web merchant strategy and order fulfillment center.

From 1999 to late 2005 Mr. Molinari was the Manager of Strategic Alliances and Licensing at Thomson CenterWatch, a Boston-based publishing and media company that focuses on the clinical trial industry. CenterWatch.com is the world’s most successful clinical trials website for patients and industry professionals. By building innovative strategic alliances with companies such as Abbott Laboratories, Roche Pharmaceuticals, Discovery Health Channel, Yahoo! Health, and WebMD.com, Mr. Molinari helped CenterWatch build and sustain one of the most respected brand names in the clinical trials industry.

Mr. Molinari also had a successful career in the consumer electronics industry, where from 1994 to 1998 he headed the marketing efforts for Terk Technologies (now a division of Audiovox), a well-known NY-based manufacturer of wireless and RF accessory products. Through inventive point-of-purchase marketing programs, Mr. Molinari was able to help Terk achieve national brand exposure with retailers such as Best Buy, Circuit City, Tweeter, and Radio Shack.

In addition to being heavily involved in the initial sales and marketing activities for CTA, Mr. Molinari is responsible for establishing the relationships that will serve as the foundation of our operational infrastructure.

Mr. Molinari received a B.S. in Business Administration from Marist College in Poughkeepsie, NY and his M.B.A. from Northeastern University in Boston, MA. At Northeastern he concentrated his studies in marketing and supply chain management.